Table 3. Treatment of High-Dose Therapy... | American Society of Hematology

Table 3.

Treatment of High-Dose Therapy Patients

	No.
Initial treatment
Chemotherapy only	30
Chemotherapy and radiotherapy	22
Radiotherapy only	8

First chemotherapy course
MOPP/ABV(D)^3-150	25
ABVD^3-151	13
MOP(P)†/CMOPP^3-152	11
Stanford Vρ	4
PAVe^3-155	4
NOVP¶, DHAP^3-151	2
MOP(P)/PAVe^3-155	1

Cytoreductive therapy before HDT
DHAP^3-151	17
MOP(P)^3-151	13
MOPP/ABV(D)^3-150	8
Radiotherapy	7
Stanford Vρ	6
ABVD^3-151	5
Other chemotherapy	4

	No.
Initial treatment
Chemotherapy only	30
Chemotherapy and radiotherapy	22
Radiotherapy only	8

First chemotherapy course
MOPP/ABV(D)^3-150	25
ABVD^3-151	13
MOP(P)†/CMOPP^3-152	11
Stanford Vρ	4
PAVe^3-155	4
NOVP¶, DHAP^3-151	2
MOP(P)/PAVe^3-155	1

Cytoreductive therapy before HDT
DHAP^3-151	17
MOP(P)^3-151	13
MOPP/ABV(D)^3-150	8
Radiotherapy	7
Stanford Vρ	6
ABVD^3-151	5
Other chemotherapy	4

See Canellos et al1 and Klimo and Connors.28

See text.

See Longo et al.29

ρ See Bartlett et al.30

See Hoppe et al.27

Novantrone, vincristine, etoposide, prednisone.